Andrew Kimball, MD
Vascular Surgery · Grand Rapids, MINPI 1700147873
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,125 of the $8,288 with a category attached, or 61.8%. 24 manufacturers reported payments, led by Cook Medical LLC at 46.5% of the total.
Across 108 payments — averaging $76.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Medical LLC$4K
- Cook Incorporated$1K
- W. L. Gore & Associates, Inc.$953
- Medtronic$342
- Silk Road Medical, Inc.$315
- Boston Scientific$290
- plus $1K from 18 others
What the payments were for
- Travel & lodging$3,16338%
- Food & beverage$5,12562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Medical LLC | 38 | $3,856 |
| Cook Incorporated | 3 | $1,162 |
| W. L. Gore & Associates, Inc. | 18 | $953 |
| Medtronic | 3 | $342 |
| Silk Road Medical, Inc. | 3 | $315 |
| Boston Scientific | 5 | $290 |
| Bolton Medical Inc | 2 | $280 |
| Kerecis Limited | 5 | $229 |
| Lemaitre Vascular, Inc. | 5 | $163 |
| Cardiovascular Systems Inc. | 1 | $133 |
| Abbott | 4 | $104 |
| Johnson & Johnson | 3 | $71 |
| Angiodynamics, Inc. | 3 | $64 |
| Endologix LLC | 2 | $63 |
| Stryker | 2 | $59 |
| Cordis US CORP. | 2 | $38 |
| Shockwave Medical, Inc | 2 | $30 |
| Integra Lifesciences Corporation | 1 | $26 |
| Cardiva Medical, Inc. | 1 | $23 |
| BD | 1 | $20 |
| KCI USA, Inc. | 1 | $19 |
| Solventum Corporation | 1 | $19 |
| Teleflex LLC | 1 | $15 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zenith Alpha$2,075
- Zilver PTX$946
- Zenith Spiral-Z$763
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$332
- ENROUTE Transcarotid Stent$285
- ENROUTE Transcarotid Neuroprotection System$285
- Cook$248
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$237
- Ranger$169
- ENDURANT IIS$162
- Relay Grafts$150
- Diamondback Peripheral$133
- TREO ABDOMINAL STENT-GRAFT SYSTEM$130
- Endurant$127
How this compares
$8,288 in reported general payments places this provider in the 70th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 37 | $30,064 |
| ClopidogrelClopidogrel Bisulfate | 111 | $1,636 |
| Atorvastatin Calcium | 57 | $729 |
| Gabapentin | 26 | $275 |
| Rosuvastatin Calcium | 11 | $269 |
| Bupropion Hcl SrBupropion Hcl | 12 | $107 |
| Prednisone | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $71 | $30,06437 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 183 vascular surgery providers in Michigan.
Other vascular surgery in Grand Rapids
- Eanas YassaGrand Rapids$81K
- Jurgen RunschkeGrand Rapids$37K
- Robert CuffGrand Rapids$23K
- M Ashraf MansourGrand Rapids$14K
- Vikram KashyapGrand Rapids$10K
- Jake NicholsonGrand Rapids$8K
- Nicolas MouawadWest Branch$1.7M
- Enrique Criado PallaresMidland$800K
- Jordan KnepperEast Lansing$336K
- Joseph CuppariClinton Township$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.